Sunshine Biopharma, Inc.

SBFM·NasdaqCM
Compare
0.3020−0.0358 (−10.60%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours0.2999−0.0021 (−0.70%)Oct 12, 7:57 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.3378
Open0.3040
Day range0.28240.3295
52-week range0.282424.3000
Off day high−8.35%
Off 52-week high−98.76%
Volume2.42M
Avg. volume (3M)5.36M
Market cap1.30M
EPS (TTM)-9.45
Forward P/E0.00
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)—
Shares outstanding4.31M
Short interest—
Earnings dateAug 14, 2025 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
SBFM RDHL UPC CPIX LFCR AQST
Market cap 1.30M 4.74M 20.75M 104.88M 244.11M 603.71M
P/E (TTM) — — — — — —
Forward P/E 0.0 17.8 — 50.0 -8.3 -8.4
Price/book 0.0 0.6 0.0 6.0 -7.1 -10.7
Dividend yield — — — — — —
1-year change −97.83% −66.93% −34.96% +107.10% −2.42% −30.09%
Today −10.60% −1.04% −0.48% −0.43% −0.16% +0.63%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All SBFM news ›
The Globe and Mail·

Sunshine Biopharma Completes $6 Million Public Offering

Sunshine Biopharma ( (SBFM) ) has provided an update. Spark’s Take on SBFM Stock According to Spark, TipRanks’ AI Analyst, SBFM is a Neutral. More about Sunshine Biopharma Current Market Cap: $3.02M For detailed information about SBFM…

Seeking Alpha·Positive

Sunshine Biopharma announces pricing of $6M public offering

Sunshine Biopharma (SBFM) priced a $6M public offering at $0.55/unit with Series D warrants, closing Oct. 9. - Sunshine Biopharma (SBFM) on Thursday announced the pricing of a public offering made on a reasonable best efforts basis with…

StocksToTrade·

SBFM Stock Pops As Sunshine Biopharma Pushes Antiviral, Generics

Sunshine Biopharma Inc. stocks have been trading up by 47.13 percent amid heightened optimism surrounding its latest biotech developments. SBFM has been trading like a classic low-priced biotech with a news catalyst. In the multi-day…

Argaam·Positive

Avalon Pharma secures exclusive rights to market Tirzepatide

Avalon Pharma can request the transfer of manufacturing technology after the product’s commercial launch. Middle East Pharmaceutical Industries Co. (Avalon Pharma) signed a licensing agreement with OneSource Specialty Pharma Ltd., granting…

@StockTitan_net·

Sunshine Biopharma: Alta reports 4.905% stake

Warrants for 200,000 shares feature in Alta’s amended Sunshine Biopharma (SBFM) stake report. Stock Titan - [SCHEDULE 13G/A] Sunshine Biopharma Inc. Amended Passive Investment Disclosure Sunshine Biopharma: Alta reports 4.905% stake…

From articles in the 4Search news index.

In the news

14mentions in 30 days
10with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 14 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.